Healthcare workers across the country are invited to join the HERO Registry, a large, national clinical research community sharing clinical and life experiences to understand the perspectives and problems they face on the COVID-19 pandemic front lines.
The HERO Registry is open to all healthcare workers, defined as anyone who works in a setting where people receive healthcare. This includes nurses, therapists, physicians, emergency responders, food service workers, environmental service workers, interpreters, transporters and others.
Registry participants could have the opportunity to participate in future research studies to improve our understanding of COVID-19 and beyond, generating evidence to help keep healthcare workers safe and healthy.
The first study, the , is a randomized clinical trial of approximately 15,000 HERO Registry participants. It will test whether hydroxychloroquine (HCQ, brand name Plaquenil) can prevent COVID-19 infection in healthcare workers.
You can download a sample email here to forward to any healthcare workers at Vanderbilt or across the country who may be interested in signing up for the registry.
We hope to start recruitment of VUMC healthcare workers from the HERO registry into the HERO-HCQ Trial next week.
Please email us at email@example.com with questions related to Vanderbilt’s engagement.
Thanks for your interest,
Sean Collins and Russell Rothman
On Behalf of the VUMC HERO team